Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Pai C. Kao"'
Publikováno v:
Annals of clinical and laboratory science. 46(1)
The prevalence of diabetes in China has surged from 0.67% before 1980 to 11.6% currently. It is even higher than the prevalence in the United States. Certainly, China's economic open-ups, improving living standard, and modernization have propagated t
Publikováno v:
Mayo Clinic Proceedings. 72:1111-1115
To report the high prevalence of increased parathyroid hormone-related peptide (PTHrP) in patients with islet cell carcinoma and associated hypercalcemia.We conducted a retrospective study of PTHrP levels in patients with hypercalcemia and eucalcemia
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 82:151-155
To determine the efficacy of cortisol and its metabolite, cortisone, measured simultaneously by high performance liquid chromatography (HPLC) in the diagnosis of Cushing's syndrome, we retrospectively reviewed the histories of 29 surgically proven Cu
Publikováno v:
Mayo Clinic Proceedings. 70:481-487
Objective To report the clinical responses and mediator-release profiles of an aspirin-sensitive man with systemic mast cell disease during aspirin desensitization. Material and Methods We quantified the release of six mediators during aspirin desens
Autor:
Qiang Cai, Rajesh Kumar, Stephen F. Hodgson, Vanda A. Lennon, George G. Klee, Alan R. Zinsmiester, Pai C. Kao
Publikováno v:
New England Journal of Medicine. 330:1645-1649
In tumor-induced osteomalacia, a rare syndrome characterized by hypophosphatemia, hyperphosphaturia, low plasma 1,25-dihydroxyvitamin D concentrations, and osteomalacia,1–5 all biochemical and pathological abnormalities disappear when the tumor is
Autor:
Roland R. Brandt, Denise M. Heublein, Christopher G.A. McGregor, Richard J. Rodeheffer, Chi Ming Wei, John C. Burnett, Amir Lerman, R. Scott Wright, Pai C. Kao, William D. Edwards
Publikováno v:
Circulation. 89:1580-1586
BACKGROUND Although recent investigations report the elevation of plasma endothelin (ET) in congestive heart failure (CHF), it remains unclear if this elevation is that of the biologically active peptide ET-1 or of its precursor big-ET. Furthermore,
Publikováno v:
Clinical Chemistry. 38:1494-1500
The performance and clinical utility of an automated assay of intact parathyroid hormone (parathyrin, PTH) are evaluated. The method is based on the extraction of PTH from plasma by an HPLC column containing immobilized anti-(44-68 PTH) antibodies. T
Publikováno v:
Mayo Clinic Proceedings. 67:637-645
Three immunometric assays of parathyroid hormone (PTH)--a commercial immunoradiometric assay, an in-house immunoradiometric assay, and an immunochemiluminometric assay--were evaluated in 50 patients with surgically proven primary hyperparathyroidism.
Publikováno v:
Mayo Clinic Proceedings. 65:1399-1407
We developed and validated a radioimmunoassay for circulating human parathyroid hormone-related peptide (PTHrP), based on a commercial antiserum to the synthetic 1-34 fragment of PTHrP, 125I-Tyr degrees-PTHrP(1-34) as radioligand, and prior extractio
Publikováno v:
Annals of clinical and laboratory science. 37(2)
The goal was to investigate the effect of micronized fenofibrate, a hypolipidemic drug, on inflammatory markers and proinsulin in patients with type 2 diabetes who had hyperlipidemia. Thirty-nine patients were treated with micronized fenofibrate (200